Indraprastha Medical Corporation Share Price
354.85-1.50 (-0.42%)
-25.75% past 1 Year
News
Indraprastha Medical Corp Q1 EBITDA rises despite slight margin compression
Equity
INDRAMEDCO
Indraprastha Medical Corp Q1 revenue grows year-on-year to Rs 410 crores
Equity
INDRAMEDCO
Indraprastha Medical Corp reports higher Q1 net profit year on year
Equity
INDRAMEDCO
Indraprastha Medical Corp Announces Final Dividend of Rs 4 Per Share
Equity
INDRAMEDCO
Indraprastha Medical Corp Q4 EBITDA Slightly Declines to Rs 60.40 Crores, Margin at 16.57% YoY
Equity
INDRAMEDCO
Indraprastha Medical Corp Q4 FY Results: Slight Profit Rise, Strong Revenue Growth
Equity
INDRAMEDCO
Indraprastha Medical Corp Q3 EBITDA Rises 16.8% YoY to Rs 61.50 Crores, Margin Expands to 16.53%
Equity
INDRAMEDCO
Indraprastha Medical Corp Q3 Net Profit Rises 25% YoY to Rs 41 Crores, Revenue Up 14% to Rs 370 Crores.
Equity
INDRAMEDCO
Indraprastha Medical Corp Q2 FY26: Revenue grows to Rs 380 crores, YoY increase confirmed.
Equity
INDRAMEDCO
Indraprastha Medical Corp Q2 FY26 EBITDA rises YoY; margin improvement recorded
Equity
INDRAMEDCO
Indraprastha Medical Corp Q2 FY2026 Standalone Net Profit Rises 16.65% YoY to Rs 49.46 crores.
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q1 Ebitda 72.60 Crores Rupees Vs 68.00 Crores (Yoy) || Q1 Ebitda Margin 19.89% Vs 19.54% (Yoy)
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q1 Sl Net Profit 51.50 Crores Rupees Vs 44.80 Crores (Yoy) || Q1 Revenue 370.00 Crores Rupees Vs 350.00 Crores (Yoy)
Equity
INDRAMEDCO
Indraprastha Medical Corp: Co Declared Dividend Of 4.5 Rupees Per Equity Share
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q4 Ebitda 61.50 Crores Rupees Vs 48.40 Crores (Yoy) || Q4 Ebitda Margin 18.41% Vs 15.39% (Yoy)
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q4 Sl Net Profit 41.00 Crores Rupees Vs 31.20 Crores (Yoy); 32.80 Crores (Qoq) || Q4 Revenue 330.00 Crores Rupees Vs 314.00 Crores (Yoy)
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q3 Ebitda 52.70 Crores Rupees Vs 47.50 Crores (Yoy) || Q3 Ebitda Margin 16.22% Vs 15.54% (Yoy)
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q3 Sl Net Profit 32.80 Crores Rupees Vs 29.40 Crores (Yoy) || Q3 Revenue 325.00 Crores Rupees Vs 306.00 Crores (Yoy)
Equity
INDRAMEDCO
Indraprastha Medical Corp: Co Issues Disclosure Regarding Media Allegations Concerning An Associate Doctor || Co Says Alleged Irregularities On Kidney Transplant Practices Not At Our Hospital
Equity
INDRAMEDCO
Indraprastha Medical Corp: Q2 Ebitda 63.60 Crores Rupees Vs 50.40 Crores (Yoy) || Q2 Ebitda Margin 18.19% Vs 15.89% (Yoy)
Equity
INDRAMEDCO